Medical Letter On Drugs And Therapeutics

Medical Letter On Drugs And Therapeutics英文简介

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

Medical Letter On Drugs And Therapeutics中文简介

《Medical Letter On Drugs And Therapeutics》是一本由MED LETTER INC出版商出版的专业医学期刊，该刊创刊于1959年，刊期Biweekly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：药学 4区；在JCR（Journal Citation Reports）分区等级为Q4。该刊发文范围涵盖药学等领域，旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为1.677，平均审稿速度较慢,6-12周。

中科院分区最新升级版（当前数据版本：2021年12月最新升级版）

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	4区	PHARMACOLOGY & PHARMACY 药学	4区	否	否

JCR分区（当前数据版本：2021-2022年最新版）

JCR分区等级	JCR所属学科	分区	影响因子
Q4	PHARMACOLOGY & PHARMACY	Q4	1.677

期刊指数

影响因子	h-index	Gold OA文章占比	研究类文章占比	OA开放访问	平均审稿速度
1.677	18	0.00%	100.00%	未开放	较慢,6-12周

IF值(影响因子)趋势图